Analyst Ratings for 4D Molecular Therapeutics (FDMT)
FDMT Rating Summary
FDMT Price Target Summary
- Highest: $37.00 (B.Riley)
- Lowest: $17.00 (Leerink)
- Average: $29.78
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$29.78 (+145.3%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
Avg. $ Target:
$29.78 (+145.3%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/14/2026 | Cantor Fitzgerald | Joshua Schimmer | Upgrade | Overweight (Neutral) |
N/A (N/A) |
13.17 (12.14) |
-7.82% | Details |
| 7/31/2026 | B.Riley » Updated 10/1/2026 |
Mayank Mamtani | New Coverage | Buy (N/A) |
37.00 (N/A) |
9.61 (12.14) |
26.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
